Logipharma report: A fast-track learning exercise in pharma supply chain innovation

Document

Go to document
In Q4 of 2021, WBR Insights surveyed 100 Directors of Supply Chain Management and similar from pharma organizations across Europe and North America to find out about the challenges they face in 2021 and the innovative solutions they are putting in place.
The results were compiled by WBR Insights and are presented in this report with analysis and commentary by TSS and the LogiPharma community.

How the pharma supply chain is stronger and more resilient in 2021

The COVID-19 pandemic revealed the existing weaknesses in the global supply chain. However, the survey revealed that in the past 12 months, pharmaceutical and biotechnology organizations had accelerated the implementation of enhanced technology to make supply chains faster and more efficient. According to the respondents, process refinement and automation are adopted at nearly every stage to improve efficiency. Novel technologies such as the IoT, ML, blockchain are revolutionizing the meaning of compliance and product transparency and accelerating order fulfilment.

The pharma supply chain is now much better prepared to respond to future macroeconomic crises by embracing powerful technologies. With the widespread adoption of IoT loggers and trackers, it is now possible to follow a shipment from the moment it leaves a facility until it reaches its destination. COVID-19 has prompted a pivotal shift in pharma supply chain strategies. The more resilient networks of today will hold it in good stead for years to come.

‍

Leveraging innovative tech for end-to-end supply chain monitoring

Our CEO Niclas Ohlsson shares the TSS view on how end-to-end visibility is the key to creating more efficient, cost-effective and sustainable pharma supply chains.
Get access to the full survey and report by completing the form below.

‍


You may also be interested in

What is Quality?

According to Lie Berglind, Chief Quality Officer at TSS, quality management is the soul of every organization. It is about doing what we say we should do, but also about measuring and determining how it was done, as well as documenting it to discover opportunities for improvement.
Read moreDownload Whitepaper
A person using a tablet with a high-tech interface, illustrating advanced data analysis for rapid decision-making.

How can maturity in temperature management move your decision process from days to seconds?

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.
Read moreDownload Whitepaper

On-demand webinar: Digitalization and its impact on the pharma supply chain

Get introduced about how to implement digital efficiencies and inform the future of medical supply chains.
Read moreDownload Whitepaper

You may also be interested in

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more
People seated at round tables in a conference room watching a presenter speak in front of a large screen displaying a pie chart.

Working Together to Make Clinical Trials Faster and Safer

TSS recently hosted the TSS User Forum 2025, bringing together leading experts from the life science industry to discuss how automation, data integrity, and collaboration can make temperature management in clinical trials faster, safer, and more reliable.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.